Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Acquisitions (2020 - 2024)

Definitive Healthcare (DH) has disclosed Acquisitions for 5 consecutive years, with $13.5 million as the latest value for Q1 2024.

  • For the quarter ending Q1 2024, Acquisitions changed N/A year-over-year to $13.5 million, compared with a TTM value of $13.5 million through Dec 2024, down 69.95%, and an annual FY2024 reading of $13.5 million, down 69.95% over the prior year.
  • Acquisitions was $13.5 million for Q1 2024 at Definitive Healthcare, down from $45.0 million in the prior quarter.
  • Across five years, Acquisitions topped out at $56.5 million in Q1 2022 and bottomed at -$203000.0 in Q3 2022.
  • Average Acquisitions over 5 years is $28.4 million, with a median of $27.8 million recorded in 2020.
  • The sharpest move saw Acquisitions skyrocketed 157.53% in 2021, then skyrocketed 22278.82% in 2023.
  • Year by year, Acquisitions stood at $15.5 million in 2020, then surged by 157.53% to $40.0 million in 2021, then tumbled by 100.51% to -$203000.0 in 2022, then surged by 22278.82% to $45.0 million in 2023, then tumbled by 69.95% to $13.5 million in 2024.
  • Business Quant data shows Acquisitions for DH at $13.5 million in Q1 2024, $45.0 million in Q3 2023, and -$203000.0 in Q3 2022.